Tag
A study of more than 140,000 Medicare patients with rheumatoid arthritis found that those on any biologic drug were 17 percent less likely than those using only a traditional DMARD to have developed dementia.
By CreakyStaff
The American College of Rheumatology’s 2020 medical conference had a number of important updates that people living with psoriatic arthritis (or their caregivers) should know about, from the future of personalizing treatment to preventing PsA in high-risk people.
By CreakyStaff
The American College of Rheumatology’s 2020 medical conference had a number of important updates that people living with osteoarthritis (or their caregivers) should know about, from the safety of steroid injections to the benefits of walking on disease progression.
By CreakyStaff
The American College of Rheumatology’s 2020 medical conference had a number of important updates that people living with gout (or their caregivers) should know about, from the minimal role of diet as a gout trigger to new thinking about how to manage hard-to-treat gout cases.
By Kelsey Kloss
A new study shows that lupus patients who need to take hydroxychloroquine can be reassured that it does not have a significant risk for serious heart toxicity.
Certain risk factors, like being younger, obese, or having enthesitis, were linked with greater delays in PsA diagnosis.
By Kelsey Kloss
New research shows that use of hydroxychloroquine did not predict prolonged QTc, a key measure of heart rate.
By Kelsey Kloss
New research sheds more light on the racial health disparities that exist in arthritis treatments.
By Kelsey Kloss
Methotrexate, commonly used in inflammatory forms of arthritis such as rheumatoid and psoriatic arthritis, could be helpful for targeting local and systemic inflammation in osteoarthritis when conventional therapies are not.
By Kelsey Kloss
The medication romosozumab may be more effective at boosting hip and spine bone density when it’s given before other kinds of drugs called antiresorptive medications.
By 
